Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Jazz posts $13M profit for third quarter
Bizjournals.com
Thursday, November 4, 2010 - 10:09pm
tags:
earnings, Jazz Pharmaceuticals
Targacept profit nearly doubles
Bizjournals.com
Thursday, November 4, 2010 - 10:07pm
tags:
earnings, Targacept
[video]Teva Performance Tough Pill to Swallow
CNBC
Thursday, November 4, 2010 - 10:02pm
tags:
Teva Pharmaceuticals
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thursday, November 4, 2010 - 10:00pm
tags:
MannKind, lawsuits, diabetes, fraud, Afrezza
Pfizer Bone Drug Reduces Breast Cancer Risk in Older Women
Bloomberg
Thursday, November 4, 2010 - 9:59pm
tags:
breast cancer, Pfizer, Fablyn
Are Monthly Numbers Necessary, Dendreon?
Motley Fool
Thursday, November 4, 2010 - 9:58pm
tags:
Dendreon, Provenge, prostate cancer
Access Pharma: On track to advance its pipeline
Yahoo/Zacks.com
Thursday, November 4, 2010 - 12:03pm
tags:
Access Pharmaceuticals, earnings
Spectrum Pharma tales 3Q loss as costs rise
Yahoo/AP
Thursday, November 4, 2010 - 12:01pm
tags:
earnings, Spectrum Pharmaceuticals
Investing in Johnson & Johnson While Still Enjoying Diversification
Seeking Alpha
Thursday, November 4, 2010 - 11:51am
tags:
JNJ
Myriad Beats by a Penny
Yahoo/Zacks.com
Thursday, November 4, 2010 - 11:47am
tags:
Myriad, earnings
ChemoCentryx attempts oral autoimmune drug
Fierce Biotech
Thursday, November 4, 2010 - 11:37am
tags:
ChemoCentryx, autoimmune disease
China blesses Sanofi ($SNY) foray into OTC meds
Fierce Pharma
Thursday, November 4, 2010 - 11:35am
tags:
OTC, China, Sanofi, Hangzhou Minsheng
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thursday, November 4, 2010 - 11:33am
tags:
MannKind, fraud, Afrezza, inhaled insulin, diabetes
Onyx lead gainer in drug sector
Marketwatch
Thursday, November 4, 2010 - 11:31am
tags:
earnings, ONYX Pharmaceuticals
Cadence Wins FDA Approval for Painkiller, Now Just Has to Sell It
Seeking Alpha
Thursday, November 4, 2010 - 11:12am
tags:
FDA, painkillers, Cadence Pharmaceuticals, Ofirmev
Inspire Pharma 3Q loss narrows on Azasite sales
Yahoo/AP
Thursday, November 4, 2010 - 11:11am
tags:
earnings, Inspire
Judge Upholds Verdict Against Pfizer Over Neurontin
Pharmalot
Thursday, November 4, 2010 - 11:09am
tags:
Pfizer, Neurontin, epilepsy
Celera Misses, Lowers Outlook
Yahoo/Zacks.com
Thursday, November 4, 2010 - 11:07am
tags:
Celera, earnings
Loss at REGN Wider than Expected
Yahoo/Zacks.com
Wednesday, November 3, 2010 - 7:17pm
tags:
earnings, Regeneron, Sanofi, AstraZeneca
Par Pharma Shares Popped: What You Need to Know
Motley Fool
Wednesday, November 3, 2010 - 7:16pm
tags:
Par Pharmaceutical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.